P11: USING ULTRASOUND TO CHARACTERISE AND HELP MANAGE OVARIAN MASSES: EXPERIENCE OF USING THE IOTA ADNEX MODEL AND SIMPLE RULES
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Diagnostic accuracy of IOTA ADNEX and IOTA LR2 model compared with subjective assessment (SA) in differentiating benign and malignant ovarian masses M. Pietryga, A. Horala, A. Paluszkiewicz, N. Izycka, K. Tobola, P. Banach, J. Brazert, E. Nowak-Markwitz
Ultrasound Oncology Poznan University Team, Department of Obstetrics and Women's Diseases & Department of Oncology, Karol Marcinkowski Poznan University of Medical Sciences, Poznan, Poland
Objectives: The purpose of our study was to compare the diagnostic accuracy of two IOTA models -ADNEX and LR2 -and SA in predicting histopathological result of adnexal masses. Methods: This is a prospective ongoing study at Poznan University Hospital. From September 2016 till March 2017 90 ovarian masses in women undergoing surgery were analysed. 65% women were premenopausal and 35% were postmenopausal. Adnexal lesions were evaluated with transvaginal ultrasound according to IOTA rules and definitions. Images were collected by 5 fellows and interpreted by 2 expert sonographers. Serum concentration of CA 125 was measured prior to surgery. The definitive diagnosis was determined on the basis of the histopathological outcome of excised lesions. Results: Mean age of women included in the study was 42,90 +/-15,25 years. Of the 90 masses 16,6% were malignant, 80% benign and 3,3% borderline. The AUC of the ADNEX model for the mere discrimination between benign and malignant tumours was 0, 92 (95% CI 0, 96) . AUC for the subtypes of malignancy ranged between 0,76 (95% CI 0,69-0,82) and 0,82 (95% CI 0,79-0,84). The AUC's of the LR2 model and SA were 0, 85 (95% CI 0, 90) and 0, 93 (95% CI 0, 96) , respectively. Discriminative performance was also assessed by computing sensitivity, specificity, positive and negative likehood ratio, positive and negative predictive value for the following cut-offs for the risk of malignancy: 5%, 10% and 15%. Sensitivity of the ADNEX model was 90,9% (95% CI 88,6%-92,3%) for all cut-offs while its specificity was the highest for the cut-off of >15%. In the LR2 model the optimal combination of highest sensitivity and specificity [86, 8% (95% CI 83, 8%) and 59,2%] was obtained for the cut-off of >10%. Conclusions: SA was moderately superior to the ADNEX model in discriminating malignant and benign ovarian masses. ADNEX model showed high sensitivity in discriminating between tumour subgroups. LR2 model was less accurate than ADNEX and SA in pre-surgical evaluation of malignancy.
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Performance of IOTA ADNEX model in differentiating histological subtypes of borderline ovarian tumours M. Gedgaudaite, S. Paskauskas, A. Gaurilcikas
Obstetrics and Gynecology, Lithuanian University of Health Sciences, Kaunas, Lithuania
Objectives: To analyse the performance of IOTA ADNEX model for the differentiation of histological subtypes of borderline ovarian tumours (BOT). Methods: Retrospective analysis of ultrasound (US) dataset of patients diagnosed with BOT on the final histology was done at the tertiary oncology centre in the period of [2009] [2010] [2011] [2012] [2013] [2014] [2015] [2016] . The IOTA ADNEX model (web application) was used to calculate the absolute risk (AR) and the relative risk (RR) for the mass being BOT. Results: 57 (72.2%) of patients were diagnosed with serous BOTs (s_BOTs) and 22 (27.8%) with mucinous BOTs (m_BOTs). Without CA-125, according to AR, the ADNEX correctly classified 37 (64.9%) serous and 12 (54.5%) mucinous BOTs with no difference between the groups. According to RR, the test correctly differentiated 44 (77.2%) serous BOTs and 15 (68.2%) mucinous BOTs (p=0.409 between the groups). When tumours were classified according to RR, the performance of ADNEX increased by 35% and 30% in s_BOTs and m_BOTs groups respectively (p<0.05). When CA-125 was added, according to AR, 35 (68.6%) of s_BOTs and 11 (57.9%) m_BOTs were correctly classified. According to RR, 41 (80.4%) of s_BOTs and 14 (73.7%) of m_BOTs were classified correctly. The performance of ADNEX model increased by 37.5% in both groups when differentiating tumours according to RR vs. AR (p<0.05). The mean AR and RR was significantly higher in s_BOTs compared to m_BOTs group (30.8% vs. 18.1% and 4.89 vs. 2.88, respectively; p=0.002). However, when CA-125 was added, the difference of mean AR (29.4% vs. 21.4%) and RR (4.67 vs. 3.39) slightly decreased and was no longer significant (p=0.106). Conclusions: IOTA ADNEX model works well in differentiating BOTs of different histological subtypes. The performance is better when tumours are differentiated according to the RR and the values of risk are higher in serous BOTs compared to mucinous ones.
P11.03
Ultrasound features of ovarian carcinoma in patients with BRCA 1 or BRCA 2 mutation
27th World Congress on Ultrasound in Obstetrics and Gynecology
Poster discussion hub abstracts Methods: All the patients found in our Clinic database affected by ovarian/tubaric carcinoma, who carried a mutation on BRCA1 or BRCA2 genes, and whom the ultrasonographic images were available of, have been included in our study. Results: 26 patients have been recruited in our study. In 100% of the cases histological report revealed that the patients had a high grade (G3) istotype of carcinoma. Nineteen out of twenty-six lesions (73%) were solid and six out of twenty-six lesions (23%) were multilocular-solid. In one patient out of twenty-six (4%) we found a unilocular-solid lesion. The echotexture of the lesions was heterogeneous in twenty-three out of twenty-six patients (88%) and lesions appeared to have irregular margins in twenty-two out of twenty-six of the cases (85%); lesions appeared to be hypoechoic in twenty-five out of twenty-six cases (96%). Vascularisation of the lesions was discrete to high (colour-score 3-4) in twenty-five out of twenty-six patients (96%). Twenty-three out of twenty-six patients (88%) did not have ascites; only three out of twenty-six patients (12%) presented a huge ascites at the ultrasonographic study. Conclusions: In conclusion, in our study ovarian cancer appeared to be a solid or multilocular-solid lesion and, moreover, we found ascites in only three patients (12%), data which has been confirmed by the surgery, even though in 73% of the cases cancer was found at FIGO stage IIIC or IV. Objectives: The aim of this study was to evaluate if IOTA simple rules protocol (SRP) may by effective for evaluation of ovarian masses in pregnant patients. Methods: Retrospective study analysing data of pregnant patients referred to our tertiary centre due to suspicions of ovarian masses between 2013 and 2016. All those patients suspected of adnexal mass underwent sonography according to the IOTA protocol. Surgical procedures were performed if indicated with corresponding histopathology assessment. SRP results were finally compared with histopathology. Results: 122 pregnant patients underwent sonography, 31 of them were qualified for surgery. Mean maternal age of the patients was 29 years (range 17-44). Mean gestational age was 16 weeks (range 5-38). In 90% a unilateral lesion was found and in 10% bilateral adnexal masses were identified. Histopathology evaluation confirmed malignancies in 4 cases and borderline ovarian tumours in 4 subjects. Remaining 23 masses were benign. In one case a postsurgical miscarriage was reported. Conclusions: Ovarian masses during pregnancy require cautious sonographic evaluation in order to identify patients in whom surgical intervention is indicated during pregnancy from those where a observation strategy can be followed. IOTA simple rules protocol is feasible to be used in pregnancy. Objectives: To compare subjective ultrasound assessment and the ADNEX model to differentiate benign and malignant ovarian tumours. Methods: This was a retrospective study including women with ovarian tumours who underwent surgery for these lesions. All patients underwent both transabdominal and transvaginal examination to assess tumour morphology and extent of the disease. Two expert sonographers performed all the scans. The ultrasound examiner assessed tumour morphology according to the IOTA protocol. Finally, the sonographer predicted the tumour as benign or malignant. This assessment was based on subjective evaluation based on knowledge from previously published IOTA studies and was given without knowledge of the results of the ADNEX model. Accuracy of the ADNEX was calculated for the cut-offs of 3% (ADNEX-3%) and 10% (ADNEX-10%) total risk of malignancy. The McNemar's test with the Yates continuity correction was used to compare the accuracy of subjective evaluation with ADNEX-3% and ADNEX-10%, respectively to compare subjective ultrasound assessment and the ADNEX model to differentiate benign and malignant ovarian tumours. Results: A total of 207 women were included in the study with a median (range) age of 52 (15-81) years. Subjective ultrasound evaluation had a significantly higher accuracy (91.8%) in discriminating benign and malignant ovarian tumours in comparison with ADNEX-3% (77.3%; p<0.001) and ADNEX-10% (81.6%; p<0.001). Sensitivity and sensibility of subjective ultrasound evaluation, ADNEX-3% and ADNEX-10% were respectively: 92.2% and 92.4%, 94.0% and 68.9%, 99.1% and 50.0%. Conclusions: This study shows that subjective ultrasound assessment performed by an expert sonographer is more accurate than ADNEX model using two different cut-off points in differentiating benign and malignant ovarian tumours. Future prospective studies with larger population of patients should confirm these preliminary findings.
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Could LARP1 be a driving force in ovarian cancer transformation?
A. 
